Metabolomics Study Revealing Purines as Potential Diagnostic Biomarkers of Acute Respiratory Distress Syndrome in Patients with Community─Acquired Pneumonia
Journal of Proteome Research · 2023
DOI: 10.1021/acs.jproteome.2c00788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2023. Verfasst von Fen Xiong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oujiang Laboratory, Institute of Metabonomics & Medical NMR, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China. Hauptthemen laut MEDLINE: Pneumonia, Respiratory Distress Syndrome, Community-Acquired Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Primary Research and Development Plan of Zhejiang Province, Health Innovation Talent Project of Zhejiang Province.
Abstract (Originalsprache)
Community-acquired pneumonia (CAP) is a significant threat to human health and the leading cause of acute respiratory distress syndrome (ARDS). We aimed to reveal the metabolic profiling whether can be used for assessing CAP with or without ARDS (nARDS) and therapeutic effects on CAP patients after treatment. Urine samples were collected at the onset and recovery periods, and metabolomics was employed to identify robust biomarkers. 19 metabolites were significantly changed in the ARDS relative to nARDS, mainly involving purines and fatty acids. After treatment, 7 metabolites in the nARDS and 14 in the ARDS were found to be significantly dysregulated, including fatty acids and amino acids. In the validation cohort, we observed that the biomarker panel consisted of N2,N2-dimethylguanosine, 1-methyladenosine, 3-methylguanine, 1-methyladenosine, and uric acid exhibited better AUCs of 0.900 than pneumonia severity index and acute physiology and chronic health evaluation II (APACHE II) scores between the ARDS and nARDS. Combining L-phenylalanine, phytosphingosine, and N-acetylaspartylglutamate as biomarkers for discriminating the nARDS and ARDS patients after treatment exhibited good AUCs of 0.811 and 0.821, respectively. The metabolic pathway and defined biomarkers may serve as crucial indicators for predicting the development of ARDS in CAP patients and for assessing therapeutic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oujiang Laboratory, Institute of Metabonomics & Medical NMR, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China.
- Key Laboratory of Efficacy Evaluation of Traditional Chinese Medicine and Encephalopathy Research of Zhejiang Province, Wenzhou 325035, China.
ORCID-Profile: Hong Zheng, Hongchang Gao
Förderung
- Primary Research and Development Plan of Zhejiang Province
- Health Innovation Talent Project of Zhejiang Province
Zitieren
APA
Xiong, F., Jiang, K., Chen, J., Yan, Y., Zhou, Y., Chen, Z., Zheng, H., Li, Y., & Gao, H. (2023). Metabolomics Study Revealing Purines as Potential Diagnostic Biomarkers of Acute Respiratory Distress Syndrome in Patients with Community─Acquired Pneumonia. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.2c00788
Vancouver
Xiong F, Jiang K, Chen J, Yan Y, Zhou Y, Chen Z, et al. Metabolomics Study Revealing Purines as Potential Diagnostic Biomarkers of Acute Respiratory Distress Syndrome in Patients with Community─Acquired Pneumonia. Journal of Proteome Research. 2023. doi:10.1021/acs.jproteome.2c00788
BibTeX
@article{Xiong2023,
author = {Xiong, Fen and Jiang, Kaiyuan and Chen, Jianuo and Yan, Yongqin and Zhou, Yiyang and Chen, Zihao and Zheng, Hong and Li, Yuping and Gao, Hongchang},
title = {Metabolomics Study Revealing Purines as Potential Diagnostic Biomarkers of Acute Respiratory Distress Syndrome in Patients with Community─Acquired Pneumonia},
journal = {Journal of Proteome Research},
year = {2023},
doi = {10.1021/acs.jproteome.2c00788}
}
EUVIMED